Unichem Laboratories Limited has received ANDA approval for Carbamazepine Tablets USP, 200 mg from the United States Food and Drug Administration (USFDA) to market a generic version of TEGRETOL (Carbamazepine) Tablet, 200 mg of Novartis Pharmaceuticals Corp.

Carbamazepine Tablets are indicated for use as an anticonvulsant drug and in the treatment of the pain associated with true trigeminal neuralgia. The product will be commercialized from Unichem’s Goa Plant.

Unichem Laboratories Limited is an international, integrated, specialty pharmaceutical company. The company manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in several markets across the world.

In India, the company has strong skills in product development, process chemistry and manufacturing complex API as well as dosage forms.